A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-Versus-Host Disease

Chronic graft-versus-host disease (cGVHD) induces significant morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Corticosteroids are standard initial therapy despite limited efficacy and long-term toxicity. Based on our experience using bortezomib as effective acute GV...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Herrera, Alex F., Kim, Haesook T., Bindra, Bhavjot, Jones, Kyle T., Alyea, Edwin P., Armand, Philippe, Cutler, Corey S., Ho, Vincent T., Nikiforow, Sarah, Blazar, Bruce R., Ritz, Jerome, Antin, Joseph H., Soiffer, Robert J., Koreth, John
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4465759/
https://ncbi.nlm.nih.gov/pubmed/25017765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.06.040
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi